Literature DB >> 30202392

Cancer Epidemiology: A Survey of Modifiable Risk Factors for Prevention and Survivorship.

Hannah Arem1,2, Erikka Loftfield1,2.   

Abstract

Approximately 40% of men and women in the United States will be diagnosed with cancer at some point in their lives. There have been dramatic developments in our understanding of cancer development and progression in recent decades, leading to improvements in screening and treatment, and in turn greater numbers of survivors living longer after diagnosis. Epidemiologic evidence of lifestyle-related factors and cancer risk and survival has been explored extensively in the published literature, with recommendations for cancer prevention and control and strategies for implementation evolving over time. This review summarizes the burden of cancer, general measurement issues in cancer epidemiology, and the current state of the science in specific lifestyle-related risk factors and cancer. It is estimated that one third to one half of cancers could be prevented by healthier lifestyle choices.

Entities:  

Keywords:  cancer epidemiology; lifestyle; survivorship

Year:  2017        PMID： 30202392      PMCID： PMC6124966          DOI： 10.1177/1559827617700600

Source DB:  PubMed          Journal:  Am J Lifestyle Med        ISSN： 1559-8276


  79 in total

Review 1.  Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials.

Authors:  Gordon C S Smith; Jill P Pell
Journal:  BMJ       Date:  2003-12-20

Review 2.  Nutrition and physical activity guidelines for cancer survivors.

Authors:  Cheryl L Rock; Colleen Doyle; Wendy Demark-Wahnefried; Jeffrey Meyerhardt; Kerry S Courneya; Anna L Schwartz; Elisa V Bandera; Kathryn K Hamilton; Barbara Grant; Marji McCullough; Tim Byers; Ted Gansler
Journal:  CA Cancer J Clin       Date:  2012-04-26       Impact factor: 508.702

3.  Comparing 3 dietary pattern methods--cluster analysis, factor analysis, and index analysis--With colorectal cancer risk: The NIH-AARP Diet and Health Study.

Authors:  Jill Reedy; Elisabet Wirfält; Andrew Flood; Panagiota N Mitrou; Susan M Krebs-Smith; Victor Kipnis; Douglas Midthune; Michael Leitzmann; Albert Hollenbeck; Arthur Schatzkin; Amy F Subar
Journal:  Am J Epidemiol       Date:  2009-12-21       Impact factor: 4.897

4.  Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

Authors:  Marcia L Stefanick; Garnet L Anderson; Karen L Margolis; Susan L Hendrix; Rebecca J Rodabough; Electra D Paskett; Dorothy S Lane; F Allan Hubbell; Annlouise R Assaf; Gloria E Sarto; Robert S Schenken; Shagufta Yasmeen; Lawrence Lessin; Rowan T Chlebowski
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 6.  Epidemiology of endocrine-related risk factors for breast cancer.

Authors:  Leslie Bernstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

7.  Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among White Adults in the United States.

Authors:  Mingyang Song; Edward Giovannucci
Journal:  JAMA Oncol       Date:  2016-09-01       Impact factor: 31.777

8.  Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.

Authors:  Louise Lind Schierbeck; Lars Rejnmark; Charlotte Landbo Tofteng; Lis Stilgren; Pia Eiken; Leif Mosekilde; Lars Køber; Jens-Erik Beck Jensen
Journal:  BMJ       Date:  2012-10-09

9.  A quantitative assessment of oral contraceptive use and risk of ovarian cancer.

Authors:  S E Hankinson; G A Colditz; D J Hunter; T L Spencer; B Rosner; M J Stampfer
Journal:  Obstet Gynecol       Date:  1992-10       Impact factor: 7.661

Review 10.  Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.

Authors:  Joanne W Elena; Lois B Travis; Naoko I Simonds; Christine B Ambrosone; Rachel Ballard-Barbash; Smita Bhatia; James R Cerhan; Patricia Hartge; Rebecca S Heist; Lawrence H Kushi; Timothy L Lash; Lindsay M Morton; Kenan Onel; John P Pierce; Leslie L Robison; Julia H Rowland; Deborah Schrag; Thomas A Sellers; Daniela Seminara; Xiao Ou Shu; Nancy E Thomas; Cornelia M Ulrich; Andrew N Freedman
Journal:  J Natl Cancer Inst       Date:  2012-11-28       Impact factor: 13.506
View more
  13 in total

Review 1.  An overview on possible links between aflatoxin B1 exposure and gallbladder cancer.

Authors:  Jéssica Costa; Nelson Lima; Cledir Santos
Journal:  Mycotoxin Res       Date:  2021-05-21       Impact factor: 3.833

2.  The association of skipping breakfast with cancer-related and all-cause mortality in a national cohort of United States adults.

Authors:  Dena Helo; Linda Appiah; Kishor M Bhende; Theresa L Byrd; Duke Appiah
Journal:  Cancer Causes Control       Date:  2021-02-15       Impact factor: 2.506

Review 3.  Sex Differences in Cancer Genomes: Much Learned, More Unknown.

Authors:  Chenghao Zhu; Paul C Boutros
Journal:  Endocrinology       Date:  2021-11-01       Impact factor: 5.051

Review 4.  Phytotherapy in Integrative Oncology-An Update of Promising Treatment Options.

Authors:  Amy M Zimmermann-Klemd; Jakob K Reinhardt; Moritz Winker; Carsten Gründemann
Journal:  Molecules       Date:  2022-05-17       Impact factor: 4.927

Review 5.  Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers.

Authors:  Wejdan M Alenezi; Caitlin T Fierheller; Neil Recio; Patricia N Tonin
Journal:  Genes (Basel)       Date:  2020-07-27       Impact factor: 4.096

6.  Sepsis in patients with haematological versus solid cancer: a retrospective cohort study.

Authors:  Ralphe Bou Chebl; Rawan Safa; Mohammad Sabra; Ali Chami; Iskandar Berbari; Sarah Jamali; Maha Makki; Hani Tamim; Gilbert Abou Dagher
Journal:  BMJ Open       Date:  2021-02-16       Impact factor: 2.692

Review 7.  Novel insights on gut microbiota manipulation and immune checkpoint inhibition in cancer (Review).

Authors:  Silvia Vivarelli; Luca Falzone; Giulia Costanza Leonardi; Mario Salmeri; Massimo Libra
Journal:  Int J Oncol       Date:  2021-08-13       Impact factor: 5.650

Review 8.  Melanin and Melanin-Functionalized Nanoparticles as Promising Tools in Cancer Research-A Review.

Authors:  Iasmina Marcovici; Dorina Coricovac; Iulia Pinzaru; Ioana Gabriela Macasoi; Roxana Popescu; Raul Chioibas; Istvan Zupko; Cristina Adriana Dehelean
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

9.  Effects of Lifestyle and Environmental Factors on the Risk of Acute Myeloid Leukemia: Result of a Hospital-based Case-Control Study.

Authors:  Masumeh Maleki Behzad; Mohammad Abbasi; Iman Oliaei; Somayeh Ghorbani Gholiabad; Hassan Rafieemehr
Journal:  J Res Health Sci       Date:  2021-08-12

10.  Polydatin Encapsulated Poly [Lactic-co-glycolic acid] Nanoformulation Counteract the 7,12-Dimethylbenz[a] Anthracene Mediated Experimental Carcinogenesis through the Inhibition of Cell Proliferation.

Authors:  Sankaran Vijayalakshmi; Arokia Vijaya Anand Mariadoss; Vinayagam Ramachandran; Vijayakumar Shalini; Balupillai Agilan; Casimeer C Sangeetha; Periyasamy Balu; Venkata Subbaih Kotakadi; Venkatachalam Karthikkumar; David Ernest
Journal:  Antioxidants (Basel)       Date:  2019-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.